Cargando…
Effect of vasopressin V2-receptor antagonist tolvaptan on syndrome of inappropriate antidiuresis (SIAD) after transsphenoidal pituitary surgery: recovery of measured osmolality
BACKGROUND: Delayed hyponatremia after pituitary surgery can be treated with the V2-receptor antagonist, oral tolvaptan. We investigated the pharmacological effect of oral tolvaptan against SIAD in patients with hyponatremia after pituitary surgery. METHODS: Thirty-nine patients with pituitary adeno...
Autores principales: | Tosaka, Masahiko, Yamaguchi, Rei, Itabashi, Yutaro, Mukada, Naoto, Tsuneoka, Haruka, Takahashi, Kentaro, Nakamura, Shunsuke, Nakazawa, Takahiko, Yoshimoto, Yuhei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563166/ https://www.ncbi.nlm.nih.gov/pubmed/36247169 http://dx.doi.org/10.1016/j.heliyon.2022.e10966 |
Ejemplares similares
-
Tolvaptan for the treatment of the syndrome of inappropriate
antidiuresis (SIAD)
por: Tzoulis, Ploutarchos, et al.
Publicado: (2023) -
Hyponatraemia and the syndrome of inappropriate antidiuresis (SIAD) in cancer
por: Donald, D Mc, et al.
Publicado: (2022) -
Chronic Hyponatremia Due to the Syndrome of Inappropriate Antidiuresis (SIAD) in an Adult Woman with Corpus Callosum Agenesis (CCA)
por: Silveira, Marcelo Augusto Duarte, et al.
Publicado: (2018) -
What Does SGLT2 Inhibition Add in Managing Hyponatremia Secondary to Syndrome of Inappropriate Antidiuresis (SIAD)?
por: Jalal, Fadzliana Hanum, et al.
Publicado: (2021) -
Syndrome of inappropriate antidiuresis
por: Kharb, Sandeep, et al.
Publicado: (2012)